PHIL Stock Overview
Philadelphia Pharmaceuticals PLC develops, manufactures, and markets human pharmaceutical products, cosmetics, and medical devices of various therapeutic categories in Jordan.
Philadelphia Pharmaceuticals PLC Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||د.أ1.28|
|52 Week High||د.أ1.50|
|52 Week Low||د.أ1.28|
|1 Month Change||-4.48%|
|3 Month Change||-10.49%|
|1 Year Change||-6.57%|
|3 Year Change||-17.95%|
|5 Year Change||-17.42%|
|Change since IPO||83.91%|
Recent News & Updates
|PHIL||JO Pharmaceuticals||JO Market|
Return vs Industry: PHIL underperformed the JO Pharmaceuticals industry which returned -2.6% over the past year.
Return vs Market: PHIL underperformed the JO Market which returned 21% over the past year.
|PHIL Average Weekly Movement||n/a|
|Pharmaceuticals Industry Average Movement||5.7%|
|Market Average Movement||3.8%|
|10% most volatile stocks in JO Market||6.4%|
|10% least volatile stocks in JO Market||1.9%|
Stable Share Price: Insufficient data to determine PHIL's volatility over the past 3 months.
Volatility Over Time: Insufficient data to determine PHIL's volatility change over the past year.
About the Company
|1993||152||Kayed Gazi Al-Shaabani||https://www.philapharma.com|
Philadelphia Pharmaceuticals PLC develops, manufactures, and markets human pharmaceutical products, cosmetics, and medical devices of various therapeutic categories in Jordan. The company provides products for skin related disorders, including anti-lice and scabicides preparations, antiseptics and disinfectants, bleaching and hyperpigmentation disorders preparations, emollients and protectives, keratolytics/topical psoriasis treatment preparations, and skin healing agents, as well as agents for dermatitis; and topical acne preparation, anti-pruritic, anti-viral, plain antifungal and anti-infective, plain steroid, steroids with antifungal/anti-infective combination, and skin recoloring products. It also offers products for women health, such as vaginal antifungals, alkalinizing and cleansing agents, antimicrobials, germicidal fungicidal, antiseptics and hemostatic, and vaginal progesterone; and products in the areas of alimentary, gastrointestinal system, anti-inflammatory, analgesic, antipyretic, dental-oropharyngeal, hair care, local anesthetics, and respiratory system, as well as supplements and health care-OTC products.
Philadelphia Pharmaceuticals PLC Fundamentals Summary
|PHIL fundamental statistics|
Is PHIL overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|PHIL income statement (TTM)|
|Cost of Revenue||د.أ3.47m|
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
|Earnings per share (EPS)||-0.017|
|Net Profit Margin||-2.06%|
How did PHIL perform over the long term?See historical performance and comparison